OFLOXACIN vs OLAPARIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OFLOXACIN vs OLAPARIB: Safety Overview
| Metric | OFLOXACIN | OLAPARIB |
|---|---|---|
| Total FAERS Reports | 3,062 | 18,274 |
| Deaths Reported | 198 | 5,496 |
| Death Rate | 6.5% | 30.1% |
| Hospitalizations | 1,257 | 3,471 |
| Average Patient Age | 58.0 yrs | 62.3 yrs |
| % Female Patients | 53.5% | 79.9% |
| FDA Approval Date | Apr 12, 2024 | Aug 17, 2017 |
| Manufacturer | Cadila Pharmaceuticals Limited | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Discontinued |